AlphAIAlphAI — Financial news for AI agents
investing.com$AXON

Piper Sandler lowers Axon stock price target on Dedrone delays

Piper Sandler cut Axon Enterprise's (NASDAQ:AXON) price target to $540 from $561, citing missed Q3 bookings and revenue due to Dedrone delays. The stock fell 10.6% last week. Axon's Q3 revenue rose 28% YoY but missed estimates, with EPS at $1.72 vs. $1.91 expected. Needham also lowered its target to $500 but kept a Buy rating.

Original reporting
investing.com
Published Nov 6, 2026, 2:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 2:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$AXON
Bearish
high confidence
Mentioned
$AXON
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$AXONBearishMed
01

Why it matters

Analyst target cuts and earnings miss signal a bearish short‑term outlook, but the company retains a 59.5% 12‑month gross margin and may benefit from future drone deals.

02

Market read

The news is relevant for traders with exposure to Axon or the broader security‑tech sector, indicating potential short‑term downside.

03

What to watch

Potential upside from new contracts in the drone segment and a conservative guidance approach could lead to beat‑and‑raise later in the year.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

Axon Enterprise reported Q3 revenue of $908.6 M versus $940 M expected, with adjusted EPS of $1.72 versus $1.91 consensus. The miss was driven by a $130 M removal of Dedrone revenue.

Company-level read

Ticker impact

$AXONBearishHigh confidence
Context

Piper Sandler and Needham lowered price targets on Axon after its Q3 earnings missed expectations and guidance was cut due to delayed Dedrone revenue.

Expected impact

likely further downside as the market prices in weaker guidance and reduced targets

Evidence & confidence

Analyst target reductions are fresh and quantify the perceived risk, and the earnings miss was not previously reported.

Market effects

Sector

May weigh on other public safety and law‑enforcement technology firms as investors reassess demand forecasts.

Regional

Primarily U.S. market impact; limited regional spillover.

Global

Low global relevance beyond the niche security‑tech sector.

Counterpoint

What could challenge this read

If the delayed Dedrone revenue materializes in 2027, the current price may be overly penalized.

Key entities

  • company
    Axon Enterprise

    Public safety technology firm (NASDAQ:AXON).

  • analyst
    Piper Sandler

    Equity research firm that lowered its price target to $540.

  • analyst
    Needham

    Equity research firm that lowered its price target to $500.

Read at source← All news

StoryAxon Enterprise posts record Q3 revenue, announces $1.2 bn Skydio investment and cuts full‑year guidance

Also covered by

5 outlets

Related articles

$AXONMed

Raymond James cuts Axon stock price target on federal delays

Raymond James cut Axon Enterprise's price target to $475 from $675, citing federal project delays and margin pressures. Axon's Q3 revenue rose 28% YoY to $909M, missing estimates. Adjusted EBITDA beat forecasts at $236M. The stock is down 33% YTD, trading near its 52-week low. Multiple analysts lowered price targets due to delayed federal deals and missed bookings.

investing.com
$AXONHighAI 9/10

Axon Just Bet $1.2 Billion That Drones Will Be the New First Responders

Axon Enterprise (AXON) invested $1.2B in Skydio, valuing it at $5.2B pre-investment. Axon's stake rises to 37%, with exclusive U.S./Canada distribution rights. The deal coincides with Axon's adjusted EPS miss and lowered 2026 revenue outlook. AXON stock dropped post-earnings, trading at $356.22 after hours. Skydio remains independent, focusing on autonomous drones for public safety.

247wallst.com
$AXONHighAI 8/10

Axon Enterprise earnings analysis: questions answered and next catalysts

Axon Enterprise (AXON) shares fell 18.24% to $312.79, a 52-week low, after reporting Q3 FY2026 earnings below estimates. Revenue grew 28% YoY to $908.55M, but EPS missed at $1.72 vs. $1.91. Analysts note demand is intact, with software growth strong, but hardware margins and guidance cuts raise concerns. Next catalysts include Q4 earnings, Dedrone deals, and Taser hardware recovery.

investing.com
$IONQMedAI 8/10

Stocks making the biggest moves midday: Nvidia, Moderna, IonQ, Airbnb, Firefly Aerospace & more

IonQ rose 17% after raising revenue guidance to $505M-$515M. Firefly Aerospace surged 30% on a $1.3B deal with AST SpaceMobile. Microchip Technology fell 14% due to weak guidance. Moderna gained 7% after beating earnings and raising sales outlook. Lam Research jumped 9% on a $25B buyback plan. Five9 dropped 17% after lowering EPS guidance and announcing an acquisition. Airbnb climbed 11% on strong earnings. JFrog soared 35% after raising full-year guidance.

cnbc.com
$AXONHighAI 9/10

Axon Sinks 17% on Revenue Miss, Guidance Cut and $1.2 Billion Skydio Bet on “Millions of Drones”

Axon shares dropped 17% after Q3 revenue of $909M missed estimates and the company reduced its 2026 growth outlook to 30%. The cut was driven by $130M in delayed federal Dedrone deployments, though software and services revenue grew 43%. Axon also committed $1.2B to drones via a Skydio deal, becoming its exclusive public-safety distributor. Gross margin fell to 56.7% due to memory costs.

finance.yahoo.com
$AXONHigh

Axon shares fall as RBC cuts price target on federal deal delays

RBC Capital cut Axon Enterprise's (AXON) price target to $615 from $735, citing delayed federal Dedrone deals and margin pressures. AXON shares fell 10% this week, trading 32% below their 52-week high. Despite challenges, the company reported 34.6% revenue growth and 20% year-to-date bookings growth. Piper Sandler and Needham also lowered their price targets but maintained positive ratings.

investing.com